Oberweis Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.06M | Buy |
138,900
+73,300
| +112% | +$4.78M | 0.39% | 92 |
|
|
2025
Q1 | $4.39M | Hold |
65,600
| – | – | 0.22% | 143 |
|
|
2024
Q4 | $3.63M | Buy |
65,600
+22,100
| +51% | +$1.22M | 0.17% | 157 |
|
|
2024
Q3 | $2.6M | Hold |
43,500
| – | – | 0.13% | 177 |
|
|
2024
Q2 | $2.77M | Hold |
43,500
| – | – | 0.17% | 158 |
|
|
2024
Q1 | $3.01M | Hold |
43,500
| – | – | 0.22% | 151 |
|
|
2023
Q4 | $2.4M | Buy |
43,500
+10,500
| +32% | +$579K | 0.22% | 162 |
|
|
2023
Q3 | $1.92M | Buy |
+33,000
| New | +$1.92M | 0.2% | 162 |
|
|
2015
Q4 | – | Sell |
-158,235
| Closed | -$6.25M | – | 175 |
|
|
2015
Q3 | $6.25M | Buy |
158,235
+13,450
| +9% | +$531K | 1.82% | 26 |
|
|
2015
Q2 | $8.98M | Buy |
144,785
+72,250
| +100% | +$4.48M | 2.38% | 11 |
|
|
2015
Q1 | $4.54M | Buy |
72,535
+55,735
| +332% | +$3.49M | 1.27% | 31 |
|
|
2014
Q4 | $947K | Buy |
+16,800
| New | +$947K | 0.28% | 60 |
|